Health Condition 1: B86- Scabies
Conditions
Interventions
Intervention1: Topical permethrin 5%: Topical permethrin 5% applied weekly for two weeks
Control Intervention1: Topical Spinosad 0.9%: Topical spinosad 0.9% weekly for one week
Sponsors
Dr.Noorain Hamid Khan
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are clinically diagnosed case of scabies. Household contacts of the patients. Age include Above 4 years and less than 65 years. Both sexes. Complaint of nocturnal pruritus and papules or excoriation marks over the body. Patient having typical burrows over the web spaces and involvement of flexures of upper limb, axilla, breast, and groins.
Exclusion criteria
Exclusion criteria: Age less than 4 years, pregnancy, those females planning for pregnancy in next one month and lactation. Atypical variant and scabies with secondary infection. H/O recent live vaccination, other scabicide drugs taken in recent past. Patients with anemia, liver diseases, kidney disease. Patients with malignancies or lymphoproliferative disorders. Patients on potent immunosuppresants, immunocompromised individuals. Family history of melanoma or non melanoma skin cancers. Patients unwilling to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the clinical efficacy of topical permethrin 5% vs topical spinosad 0.9% in management of scabiesTimepoint: Baseline, Week One, Week Two, Week Four, Week six | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the safety and tolerability of topical permethrin 5% vs topical spinosad 0.9% in management of scabiesTimepoint: 6 weeks | — |
Countries
India
Contacts
Public ContactDrNoorain Hamid Khan
Shri Bhausaheb Hire Government Medical College
Outcome results
None listed